Does TransEnterix have a future?
TransEnterix has projected its cash runway to last until the end of 2022. There are also many regulatory catalysts anticipated in the first half of 2020 that can further push up share prices. Hence, at the cost of a few hardships in 2020, the company has been building a solid platform for future growth.
What is TRXC company?
(NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will change its corporate name to Asensus Surgical, Inc.
Why did TransEnterix change its name?
However, if you do a Google search for TRXC stock, you may come across some strange results. That’s because Transenterix changed its name recently to Asensus Surgical (NYSEAMERICAN:ASXC), reflecting management’s decision to focus on the company’s Senhance Surgical System.
How many employees does TransEnterix have?
104 employees
How many Employees does TransEnterix have? TransEnterix has 104 employees.
Is TRXC a but?
TransEnterix currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
What happened to TransEnterix?
TransEnterix (NYSEARCA:TRXC), which is a medical devices company, announced this week that it will change its corporate name to Asensus Surgical, but there’s no telling how much that will matter to TRXC stock in the long term.
Will TransEnterix survive?
TransEnterix (NYSEAMERICAN:TRXC) now has plenty of cash to survive well into 2024, which will allow the laparoscopy robotics company to eventually produce revenue.
Is TransEnterix undervalued?
TransEnterix has a current Real Value of $3.07 per share. The regular price of the company is $3.81. In general, we recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Is TRXC a good buy?
What is TRXC stock price?
TRXC Price/Volume Stats
| Current price | $4.08 | 52-week high |
|---|---|---|
| Day low | $3.62 | Volume |
| Day high | $4.77 | Avg. volume |
| 50-day MA | $3.04 | Dividend yield |
| 200-day MA | $1.09 | Market Cap |
What happened to TRXC stock?
TRXC stock will begin trading under the new name and ticker ASXC on March 5, 2021. The company said, “the name change [to Asensus Surgical] reflects the company’s broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.”
Is TRXC a buy or sell?
Who are the officers of transenterix, Inc?
Transenterix, Inc. is listed as an officer of another company. What next? Receive an email notification when changes occur for Transenterix, Inc.. These addresses are known to be associated with Transenterix, Inc. however they may be inactive or mailing addresses only.
Who is transenterix and what is digital laparoscopy?
TransEnterix, Inc. (TRXC) – Founded in 2006 TransEnterix, enga digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy.
When did transenterix get CE mark for ultrasonic instruments?
During 2018 and 2019, the company successfully obtained FDA clearance and CE Mark for its 3 millimeter diameter instruments, its Senhance ultrasonic system, its 3 millimeter and 5 millimeter hooks, and the Senhance articulating system.
